|
|||||
|
Cerebral Palsy Associated with Low Levels of Thyroid Hormone in Premature Infants, 4/1996Two articles in the March 28, 1996 issue of the New England Journal of Medicine1 explore the relationship of a temporary low level of thyroid hormone in premature infants in the first week of life and the occurrence of severe cerebral palsy and/or mental retardation. One article is the report of a research study supported by the National Institutes of Health (NIH), the government's medical research agency; the other is an editorial review of the research area by international experts. The
articles point out that thyroxin (thyroid hormone)
is necessary for brain development and crosses the
placenta from mother to fetus. When the infant is
born, its own mechanism becomes active for the
production and adjustment of necessary levels of
thyroxin. However, it takes time for the premature
infant to take over this function; the more
premature the infant, the lower the level of
thyroxin available to it, particularly in the first
few weeks after birth. Most infants are finally able
to make the adjustment; thus the low level of
thyroxin available is usually a temporary phenomenon
-- but one that occurs at a critical time in brain
development. In
the past, several studies have shown that low levels
of thyroxin are present in infants who are mentally
retarded. The present study shows that the same is
true with those who have severe cerebral palsy. Comment Does
this temporary low level of thyroxin cause brain
damage? Or are both due to some other factor
influencing the occurrence of both? We don't know.
Should all premature infants be tested shortly after
birth for thyroxin levels? Probably. Will treating
premature infants who have low levels of thyroxin
help prevent cerebral palsy? We don't know, but a
clinical trial would tell us. The present study is important in that it identifies several specific research questions that can and need to be answered. The Research Foundation is working with the NIH to get the answers. 1 "The Relation of Transient
Hypothroxinemia in Preterm Infants to Neurologic
Development at Two Years of Age;" Reuss M.L. et al.
"Prematurity-Associated Neurologic and Developemntal
Abnormalities and Neonatal Thyroid Function;" Vulsma,
T. and Kok, J.H. © UCP Research & Educational Foundation, April 1996 |
||||
|
|||||